ERBB2 and breast cancer: Recent efforts have proposed potential cut-offs for PD-L1 positivity and TIL levels to assess their prognostic and predictive significance specifically in TN and HER2+ BC (e.g., ≥10% CPS for PD-L1, stromal TILs ≥ 10% or 20%) [65,66,67].